Literature DB >> 10956052

Cholesterol efflux to high-density lipoproteins and apolipoprotein A-I phosphatidylcholine complexes is inhibited by ethanol: role of apolipoprotein structure and cooperative interaction of phosphatidylcholine and cholesterol.

N A Avdulov1, S V Chochina, U Igbavboa, W G Wood.   

Abstract

There is a substantial body of evidence showing that moderate alcohol consumption is associated with a reduced risk of cardiovascular morbidity and mortality. One of the factors thought to contribute to this reduction in risk is an increase in the level of high-density lipoproteins (HDL) correlated with alcohol consumption. However, HDL levels are elevated in heavy drinkers, but their risk of vascular disease is greater compared with that of moderate drinkers. Ethanol at concentrations observed in heavy drinkers and alcoholics may directly act on HDL and apolipoproteins and in turn modify cholesterol efflux. In this paper, we show that ethanol significantly inhibited cholesterol efflux from fibroblasts to HDL and to apolipoprotein A-I (apoA-I) complexed with phosphatidylcholine (PC). Ethanol significantly inhibited binding of PC to apoA-I, inhibited incorporation of cholesterol only when apoA-I contained PC, and did not alter incorporation of cholesterol into HDL. ApoA-I structure was altered by ethanol as monitored by steady-state fluorescence polarization of tryptophan residues. The absence of ethanol effects on incorporation of cholesterol into HDL versus inhibition of cholesterol incorporation into the apoA-I-PC complex suggests that the effects of ethanol on cholesterol efflux mediated by HDL involve interaction with the cell surface and that efflux mediated by the apoA-I-PC complex is a combination of aqueous diffusion and contact with the cell surface. In addition, effects of ethanol on apoA-I suggest that pre-beta-HDL or lipid-free apoA-I may be more perturbed by ethanol than mature HDL, and such effects may be pathophysiological with respect to the process of reverse cholesterol transport in heavy drinkers and alcoholics.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10956052     DOI: 10.1021/bi0008534

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Development of a cell-based, high-throughput screening assay for cholesterol efflux using a fluorescent mimic of cholesterol.

Authors:  Jun Zhang; Sutang Cai; Blake R Peterson; Penny M Kris-Etherton; John P Vanden Heuvel
Journal:  Assay Drug Dev Technol       Date:  2010-11-04       Impact factor: 1.738

Review 2.  Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

Authors:  Rai Ajit K Srivastava
Journal:  Mol Cell Biochem       Date:  2017-08-21       Impact factor: 3.396

3.  A novel apoA-I mimetic peptide suppresses atherosclerosis by promoting physiological HDL function in apoE-/- mice.

Authors:  Sanhu Gou; Li Wang; Chao Zhong; Xinyue Chen; Xu Ouyang; Beibei Li; Guangjun Bao; Hui Liu; Yun Zhang; Jingman Ni
Journal:  Br J Pharmacol       Date:  2020-09-09       Impact factor: 8.739

4.  Alcohol Pattern Consumption Differently Affects the Efficiency of Macrophage Reverse Cholesterol Transport in Vivo.

Authors:  Daniela Greco; Simone Battista; Laura Mele; Antonio Piemontese; Bianca Papotti; Stefania Cavazzini; Francesco Potì; Giulia Di Rocco; Andrea Poli; Franco Bernini; Ilaria Zanotti
Journal:  Nutrients       Date:  2018-12-03       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.